Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004730 · ClinicalTrials.gov registry record · Phase 3
Magnesium Sulfate For Brain Injury
A Phase 3 study of Brain Injuries and Brain Concussion, sponsored by University of Washington.
- Completed
- Registry status
- Phase 3
- Development phase
- 1
- Study location
NCT00004730: Completed Phase 3 study of Brain Injuries and Brain Concussion, sponsored by University of Washington.
NCT00004730 is a Phase 3 study of Brain Injuries and Brain Concussion that has completed, run by University of Washington. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004730, a Phase 3 study of Brain Injuries and Brain Concussion, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1
- Study location
Study Summary
The purpose of the study is to determine whether magnesium sulfate, given within 8 hours of a moderate or severe traumatic brain injury improves survival, decreases the number of people developing seizures, improves the survivors' mental and psychological functioning, including the ability to return to daily life, live independently, and return to work or school.
Conditions Studied
Interventions
- DRUG magnesium sulfate
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-08 |
| Est. Completion | 2005-05 |
| Phase | Phase 3 |
What the finished NCT00004730 record still lists
NCT00004730 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 3 conditions, with Brain Injuries appearing as the primary indexed condition, and to 1 intervention - of which magnesium sulfate is the first listed.
NCT00004730 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT00004730 about?
NCT00004730 is a clinical study titled "Magnesium Sulfate For Brain Injury". The purpose of the study is to determine whether magnesium sulfate, given within 8 hours of a moderate or severe traumatic brain injury improves survival, decreases the number of people developing seizures, improves the survivors' mental and psychological functioning, including the ability to return...
What is the current status of trial NCT00004730?
This trial is currently completed. It is a Phase 3 study. The study started on 1998-08. Estimated completion is 2005-05.
What conditions does trial NCT00004730 study?
This clinical trial studies the following conditions: Brain Injuries, Brain Concussion, Head Injury.
What interventions are being tested in trial NCT00004730?
The interventions under investigation include: magnesium sulfate (DRUG).
Who is sponsoring clinical trial NCT00004730?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00004730 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
COMPLETED · Phase 3
-
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
RECRUITING · NA
-
The Gut-Brain Axis During Neurorehabilitation; Prebiotic Treatment to Alter the Gut Microbiome and Neurologic Symptoms
RECRUITING · NA
-
Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma
RECRUITING · NA
-
Screening Emotions in Adolescents at the Hospital for mTBI
RECRUITING
-
Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia